Hemostasis Today

June, 2026
June 2026
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Prithu Sundd on The Role of CD39 Polymorphism in Enabling Pulmonary Thrombosis in SCD
Jan 16, 2026, 12:59

Prithu Sundd on The Role of CD39 Polymorphism in Enabling Pulmonary Thrombosis in SCD

Prithu Sundd, Senior Investigator and Professor-Thrombosis and Hemostasis Program at Versiti Blood Research Institute, shared on LinkedIn:

”Very excited to share our new work on the role of CD39 polymorphism and extracellular vesicles in promoting in situ pulmonary thrombosis in Sickle Cell Disease.

Special thanks to hard work of Tomasz Brzoska, Tomasz Kaminski and SM Nouraie.

Thanks to all the collaborators, Sickle Cell Centers at PITT/UPMC and MCW/Froedtert.

Thanks to CTRO, Versiti Research, Walk-PHASST study, and NHLBI TOPMed VTE working group for their support.”

Read the full article here.

Article: CD39 polymorphism enables lung thrombosis in sickle cell disease

Authors: Tomasz Brzoska, Tomasz W. Kaminski, Omika Katoch, Elizaveta V. Menchikova, Adekunle E. Alagbe, Sarah E. Tashbook, Stevan P. Tofovic, Jude C. Jonassaint, Claudette M. St. Croix, Simon C. Watkins, Shane Howe, Joshua J. Field, Amanda A. Seyerle, Tirthadipa Pradhan-Sundd, Cecilia Laurie, Nathan D. Pankratz, Nicholas L. Smith, Ellen L. Goode, James S. Pankow, Charles Kooperberg, Gregory J. Kato, Yingze Zhang, Enrico M. Novelli, Mark T. Gladwin, Edwin K. Jackson, Seyed M. Nouraie, Prithu Sundd

Prithu Sundd on The Role of CD39 Polymorphism in Enabling Pulmonary Thrombosis in SCD

Stay updated on all scientific advances with Hemostasis Today.